Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a backend/software version update and does not modify the study details or page content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision label updated to v3.5.0; the previous Revision: v3.4.3 label was removed.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2; no user-facing content changes detected.SummaryDifference0.1%

- Check50 days agoChange DetectedPublications section added with a cited Oncoimmunology article and a note that these items are auto-filled from PubMed. This contextual information does not alter the trial details, eligibility criteria, or study design on the page.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.5%

- Check78 days agoChange DetectedA government funding status notice was added and the page revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.